Page 31 - MemoriaCIBER2019-ENG

CIBER-BBN 31
• BONESCAFF: Improved ELRs scaffolds for bone regeneration, Alessandra Girotti.
• MagTHor: Magnetic isolation of extracellular vesicles from genetically modified therapeutic human adipo-
se mesenchymal stem cells for glioblastoma treatment, Oscar Meca Cortés.
• CADHForce: Cell mechanosensing through cadherin complexes, Raimon Sunyer.
2019 has been quite a prolific year for the Biomaterials and Advanced Therapies Programme in terms of awards. The researcher María Vallet-Regí received, among others, two highly prestigious international awards: the George Winter Award 2019 and the FEMS Materials Innovation Prize 2019.
The activity at the national level includes the concession in 2019 of the Research Challenges R + D + I Projects Modality B to researcher Patricia Rico, from the group led by José Luis Gómez Ribelles.
At the international level, an individual project has been submitted to the European Research Council (ERC) Consoli- dator Grants by the researcher Patricia Rico.
It is important to mention that, since June 2019, the CIBER-BBN participates as a Stakeholder of the AEMPS (Spanish Agency for Medicines and Health Products) in the European project STARS-CSA: Strengthening Training of Academia in Regulatory Science. https://www.csa-stars.eu/index.html. This project is developed by a consortium of 18 European regulatory agencies, including the AEMPS and the EMA (European Medicines Agency), with the objective being to analyse and improve the knowledge of regulatory science of the academic research groups that direct their research to the development of innovative drugs, including advanced therapies.
Nanomedicine
Coordinator: M. Pilar Marco Colás
In 2019, seven new intramural collaborations were started in the Nanomedicine Programme, joining the 59 colla- borations already started in 2018. In addition, the 14 Early Stage projects in the nanomedicine area have also been maintained, led by contracted CIBER staff.
The effort made by the CIBER-BBN in preparing competitive proposals for both European and national calls is worth mentioning. During the year 2019, the national project “Nanoplasmonic sensor platform for biomimetic analysis and without cell immunotherapy markings - SENSCELL”, of the programme of the National Plan for the Generation of Knowledge 2018, led by Maria Soler (PI: Laura Lechuga), was started.
In addition, researchers from the CIBER-BBN Nanomedicine Programme have continued with the international and
national financed projects already underway, highlighting among them:
• European project SMART-4 FABRY “Smart functional GLA-nanoformulation for Fabry Disease”, coordinated by CIBER (PI: Nora Ventosa);
• European project PROSCANEXO “Exploitation of extracellular vesicles for precision diagnostics of prostate” ERANET-TRANSCAN-2 (JTC2016) led by Jesús Martínez de la Fuente;
• European project ABISens “Monitoring of Acquired Brain Injury and recovery biomarkers by the combined label-free nanoSensing of multiple circulating molecules” EURONANOMED-3 (JTC2018) coordinated by CIBER-BBN, PI: Laura Lechuga;
• National projects NanoET-Leukemia (RETOS R+D+i projects), and the project “Design of protein nano- medicines for targeted treatments in pancreatic cancer” AES 2017, led by CIBER researchers Anna Lagunas and Marina Inés Giannotti, and José Luis Corchero respectively;
• Worth highlighting are the ERC projects underway within the CIBER-BBN nanomedicine area such as (i) ERC Advanced Grants: María Vallet-Regí, Jesús Santamaría and Luis Liz-Marzán with the projects VERDI “poly- Vanet mEsopoRous nanosystems for bone DIseases”, CADENCE “Catalytic Dual-Function Devices Against Cancer” and 4DBIOSERS “Four-Dimensional Monitoring of Tumor Growth by Surface Enhanced Raman Scatering” respectively, and the (ii) ERC Consolidator: Manuel Arruebo NANOHEDONISM project and (iii) ERC Proof of Concept: HOTFLOW project by Jesús Martínez de la Fuente Martínez.